Obesity, Independent of p53 Gene Dosage, Promotes Mammary Tumor Progression and Upregulates the p53 Regulator MicroRNA-504

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ford, Nikki A ^a   Dunlap, Sarah M ^a   Wheatley, Karrie E ^a   Hursting, Stephen D ^a,b  

^a University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; MICRORNA; MICRORNA 504; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE DOSAGE; GENE EXPRESSION; MOUSE; NONHUMAN; OBESITY; OVARIECTOMY; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; DIET; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE DOSAGE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; MICRORNAS; OBESITY; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; WNT1 PROTEIN;

MOUSE MAMMARY TUMOR VIRUS; MURINAE; MUS;

EID: 84879549514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068089     Document Type: Article

References (57)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, et al. (2012) Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res 5: 1260-1272.
3. Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, et al. (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Cause Control 11: 533-542.
4. Reeves GK, Pirie K, Beral V, Green J, Spencer E, et al. (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335: 1134.
5. Kamineni A, Anderson ML, White E, Taplin SH, Porter P, et al. (2012) Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Cause Control epub ahead of print.
6. Flegal KM, Carroll MD, Kit BK, Ogden CL, (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA: the journal of the American Medical Association 307: 491-497.
7. DeSantis C, Howlader N, Cronin KA, Jemal A, (2011) Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev 20: 733-739.
8. Dumay A, Feugeas JP, Wittmer E, Lehmann-Che J, Bertheau P, et al. (2013) Distinct tumor protein p53 mutants in breast cancer subgroups. Int J Cancer 132: 1227-1231.
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC, (1991) p53 mutations in human cancers. Science 253: 49-53.
10. Luo J, Nikolaev AY, Imai S, Chen D, Su F, et al. (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148.
11. Harris SL, Levine AJ, (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908.
12. Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, et al. (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23: 862-876.
13. Hu W, Chan CS, Wu R, Zhang C, Sun Y, et al. (2010) Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 38: 689-699.
14. Schug TT, Li X, (2011) Sirtuin 1 in lipid metabolism and obesity. Ann Med 43: 198-211.
15. Deisenroth C, Zhang Y, (2011) The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine. Genes Cancer 2: 392-403.
16. Dhasarathy A, Kajita M, Wade PA, (2007) The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol 21: 2907-2918.
17. Liu G, Schwartz JA, Brooks SC, (2000) Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res 60: 1810-1814.
18. Hurd C, Dinda S, Khattree N, Moudgil VK, (1999) Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Oncogene 18: 1067-1072.
19. Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, et al. (2010) Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc Natl Acad Sci U S A 107: 15081-15086.
20. Shirley SH, Rundhaug JE, Tian J, Cullinan-Ammann N, Lambertz I, et al. (2009) Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res 69: 3405-3414.
21. Fuchs-Young R, Shirley SH, Lambertz I, Colby JK, Tian J, et al. (2011) P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis. Breast Cancer Res Treat.
22. Zhang X, Podsypanina K, Huang S, Mohsin SK, Chamness GC, et al. (2005) Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations. Oncogene 24: 4220-4231.
23. Creighton CJ, Chang JC, Rosen JM, (2010) Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 15: 253-260.
24. Rucklidge GJ, Edvardsen K, Bock E, (1994) Cell-adhesion molecules and metalloproteinases: a linked role in tumour cell invasiveness. Biochem Soc Trans 22: 63-68.
25. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, et al. (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) 4: 329-346.
26. Dunlap SM, Chiao LJ, Nogueira L, Usary J, Perou CM, et al. (2012) Dietary Energy Balance Modulates Epithelial-to-Mesenchymal Transition and Tumor Progression in Murine Claudin-Low and Basal-like Mammary Tumor Models. Cancer Prev Res (Phila).
27. Nogueira LM, Dunlap SM, Ford NA, Hursting SD, (2012) Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity. Endocr Relat Cancer 19: 57-68.
28. D'Assoro AB, Leontovich A, Amato A, Ayers-Ringler JR, Quatraro C, et al. (2010) Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts. Int J Oncol 37: 1167-1176.
29. Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, et al. (2009) p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 11: 694-704.
30. Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, et al. (2005) Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123: 641-653.
31. Hursting SD, Berger NA, (2010) Energy balance, host-related factors, and cancer progression. J Clin Oncol 28: 4058-4065.
32. Colbert LH, Westerlind KC, Perkins SN, Haines DC, Berrigan D, et al. (2009) Exercise effects on tumorigenesis in a p53-deficient mouse model of breast cancer. Med Sci Sports Exerc 41: 1597-1605.
33. Thiery JP, (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746.
34. Nunez NP, Perkins SN, Smith NC, Berrigan D, Berendes DM, et al. (2008) Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer 60: 534-541.
35. Hursting SD, Smith SM, Harvey AE, Lashinger LM (2011) Calories and cancer: the role of insulin-like growth factor-1. In: Leroith D, editor. The IGF System and Cancer: Springer, NY. 231-243.
36. De Angel RE, Conti CJ, Wheatley KE, Brenner AJ, Otto G, et al. (2012) The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001. Mol Carcinog.
37. Kim EJ, Choi MR, Park H, Kim M, Hong JE, et al. (2011) Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res 13: R78.
38. Ray A, Nkhata KJ, Grande JP, Cleary MP, (2007) Diet-induced obesity and mammary tumor development in relation to estrogen receptor status. Cancer Lett 253: 291-300.
39. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN, (2010) Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis 31: 83-89.
40. Hursting SD, Perkins SN, Phang JM, (1994) Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc Natl Acad Sci U S A 91: 7036-7040.
41. Hursting SD, Perkins SN, Brown CC, Haines DC, Phang JM, (1997) Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice. Cancer Res 57: 2843-2846.
42. Park H, Kim M, Kwon GT, Lim do Y, Yu R, et al. (2012) A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice. Mol Carcinog 51: 869-880.
43. Chen C, Chang YC, Liu CL, Chang KJ, Guo IC, (2006) Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat 98: 121-132.
44. Mistry T, Digby JE, Desai KM, Randeva HS, (2008) Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression. BJU Int 101: 1317-1322.
45. Ishii N, Wei M, Kakehashi A, Doi K, Yamano S, et al. (2011) Enhanced Urinary Bladder, Liver and Colon Carcinogenesis in Zucker Diabetic Fatty Rats in a Multiorgan Carcinogenesis Bioassay: Evidence for Mechanisms Involving Activation of PI3K Signaling and Impairment of p53 on Urinary Bladder Carcinogenesis. J Toxicol Pathol 24: 25-36.
46. Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, et al. (2008) Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 22: 659-669.
47. Moore T, Beltran L, Carbajal S, Strom S, Traag J, et al. (2008) Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prev Res (Phila) 1: 65-76.
48. Ma X, Yoshimoto K, Guan Y, Hata N, Mizoguchi M, et al. (2012) Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma. Neuro Oncol 14: 1153-1162.
49. Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Korner S, et al. (2011) Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A 108: 14240-14245.
50. Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, et al. (2008) Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell 134: 62-73.
51. Spike BT, Wahl GM, (2011) p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome. Genes Cancer 2: 404-419.
52. Morel AP, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, et al. (2012) EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet 8: e1002723.
53. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, et al. (2011) p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13: 317-323.
54. Kim NH, Kim HS, Li XY, Lee I, Choi HS, et al. (2011) A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 195: 417-433.
55. Shanle EK, Xu W, (2010) Selectively targeting estrogen receptors for cancer treatment. Adv Drug Deliv Rev 62: 1265-1276.
56. Ma CX, Luo J, Ellis MJ, (2010) Molecular profiling of triple negative breast cancer. Breast Dis 32: 73-84.
57. De Angel RE, Smith SM, Glickman RD, Perkins SN, Hursting SD, (2010) Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr Cancer 62: 1074-1086.